The effect of enoxaparin sodium (Clexane) on the incidence of deep vein thrombosis following electrophysiology studies and radiofrequency ablation
Phase of Trial: Phase IV
Latest Information Update: 29 May 2013
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Deep vein thrombosis
- Focus Therapeutic Use
- 30 Oct 2005 New trial record.